メカニカルハートバルブと下血腫の妊婦の管理
Jenica Thangathurai1, Shakeela Faulkner2, Nare Torosyan3
1Division of Cardiovascular Medicine, Department of Medicine, Maternal Cardiology Service, University of Southern California, Los Angeles, California, USA.
JACC. Case reports
|February 19, 2026
まとめ
機械的な心弁と重度の左心室機能不全を有する妊婦の抗凝固薬の管理は,リスクをバランスする必要があります. 低分子量ヘパリンを低分子量抗Xa標的に調整することで,複雑なケースで出血合併症を成功裏に管理することができました.
科学分野:
- 心臓病学 心臓病学
- 産科は産婦人科です.
- 薬理学 薬理学とは
背景:
- メカニカルハートバルブ (MHV) と重度の左心室機能不全 (SLVD) の妊婦の抗凝固薬の管理は,血栓形成と出血の二重リスクをもたらす.
- この臨床シナリオは,妊娠中の生理学的変化のために特に複雑です.
研究 の 目的:
- MHVsとSLVDの妊婦の抗凝固管理の成功例を記述する.
- この高リスク集団における血栓と出血のリスクをバランスさせるための戦略を強調する.
主な方法:
- 26歳の女性 (G2P1) のケースレポートで,メカニカルアオルタ弁とSLVD.
- 管理には,低分子量ヘパリン (LMWH) の慎重な定位を,下胆膜下血腫の発生後により低い治療的抗Xa標的にすることが含まれていた.
- 妊娠37週で帝王切開で出産した.
主要な成果:
- LMWHの治療的な抗Xaレベルにもかかわらず,患者は妊娠22週で大きな下血腫を発症しました.
- LMWHを,より低い治療的抗Xa標的にタイトリングすることで,血腫の安定化に成功しました.
- 患者は37週目に計画された帝王切開手術を受け,大きな合併症はなかった.
結論:
- 抗凝固目標の修正は,メカニカルバルブを使用した高リスクの妊婦の出血合併症を管理するための実行可能な戦略です.
- 抗凝固剤をより低い,しかし治療的な,抗Xa標的にタイトリングすることで,出血のリスクを効果的に均衡させ,弁血栓症を予防することができます.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
432
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
432
Mitral Stenosis III: Medical Management
328
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
328
Mitral Regurgitation IV: Nursing Management
385
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
385
Mitral Valve Prolapse II: Assessment and Management
710
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
710
Mitral Regurgitation III: Medical Management
403
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
403
Mitral Stenosis IV: Nursing Management
304
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
304


